Evaluation of three enzyme immunoassays and a loop-mediated isothermal amplification test for the laboratory diagnosis of clostridium difficile infection

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 31, Issue 11, 2012, Pages 3035-3039

  Bruins, M J ^a   Verbeek, E ^a   Wallinga, J A ^a   Bruijnesteijn Van Coppenraet, L E S ^a   Kuijper, E J ^b   Bloembergen, P ^a  

^a Laboratory of Clinical Microbiology and Infectious Diseases   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; BOTULINUM TOXIN A; BOTULINUM TOXIN B; GLUTAMATE DEHYDROGENASE ANTIGEN; UNCLASSIFIED DRUG;

ARTICLE; BACTERIAL GENE; BACTERIUM CULTURE; BACTERIUM ISOLATE; CLOSTRIDIUM DIFFICILE INFECTION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; ENZYME IMMUNOASSAY; FECES ANALYSIS; GLUD GENE; GOLD STANDARD; HUMAN; ILLUMIGENE ASSAY; INTERMETHOD COMPARISON; LOOP MEDIATED ISOTHERMAL AMPLIFICATION; MAJOR CLINICAL STUDY; NONHUMAN; POLYMERASE CHAIN REACTION; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSPECTIVE STUDY; REAL TIME POLYMERASE CHAIN REACTION; RIBOTYPING; SCREENING TEST; SENSITIVITY AND SPECIFICITY; TCDA GENE;

ANTIGENS, BACTERIAL; BACTERIAL TOXINS; BACTERIOLOGICAL TECHNIQUES; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; DNA, BACTERIAL; FECES; HUMANS; IMMUNOENZYME TECHNIQUES; NUCLEIC ACID AMPLIFICATION TECHNIQUES; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY;

EID: 84867991729     PISSN: 09349723     EISSN: 14354373     Source Type: Journal    
DOI: 10.1007/s10096-012-1658-y     Document Type: Article

References (31)

1. Aspinall ST, Hutchinson DN (1992) New selective medium for isolating Clostridium difficile from faeces. J Clin Pathol 45:812-814
2. Bauer MP, Notermans DW, van Benthem BH, Brazier JS, Wilcox MH, Rupnik M, Monnet DL, van Dissel JT, Kuijper EJ, ECDIS Study Group (2011) Clostridium difficile infection in Europe: a hospital-based survey. Lancet 377:63-73
3. Bidet P, Lalande V, Salauze B, Burghoffer B, Avesani V, Delmée M, Rossier A, Barbut F, Petit JC (2000) Comparison of PCR-ribotyping, arbitrarily primed PCR, and pulsed-field gel electrophoresis for typing Clostridium difficile. J Clin Microbiol 38:2484-2487
4. Buderer NM (1996) Statistical methodology. I. Incorporating the prevalence of disease into the sample size calculation for sensitivity and specificity. Acad Emerg Med 3:895-900
5. Chapin KC, Dickenson RA, Wu F, Andrea SB (2011) Comparison of five assays for detection of Clostridium difficile toxin. J Mol Diagn 13:395-400
6. Crobach MJ, Dekkers OM, Wilcox MH, Kuijper EJ (2009) European Society of Clinical Microbiology and Infectious Diseases (ESCMID): data review and recommendations for diagnosing Clostridium difficile-infection (CDI). Clin Microbiol Infect 15:1053-1066
7. Doing KM, Hintz MS (2012) Prospective evaluation of the Meridian Illumigene™ loop-mediated amplification assay and the Gen Probe ProGastro™ Cd polymerase chain reaction assay for the direct detection of toxigenic Clostridium difficile from fecal samples. Diagn Microbiol Infect Dis 72:8-13
8. Dubberke ER, Han Z, Bobo L, Hink T, Lawrence B, Copper S, Hoppe-Bauer J, Burnham CD, Dunne WM (2011) Impact of clinical symptoms on interpretation of diagnostic assays for Clostridium difficile infections. J Clin Microbiol 49:2887-2893
9. Eastwood K, Else P, Charlett A, Wilcox M (2009) Comparison of nine commercially available Clostridium difficile toxin detection assays, a real-time PCR assay for C. difficile tcdB, and a glutamate dehydrogenase detection assay to cytotoxin testing and cytotoxigenic culture methods. J Clin Microbiol 47:3211-3217
10. Freeman J, Bauer MP, Baines SD, Corver J, Fawley WN, Goorhuis B, Kuijper EJ, Wilcox MH (2010) The changing epidemiology of Clostridium difficile infections. Clin Microbiol Rev 23:529-549
11. Freeman J, Wilcox MH (2003) The effects of storage conditions on viability of Clostridium difficile vegetative cells and spores and toxin activity in human faeces. J Clin Pathol 56:126-128
12. Goldenberg SD, Cliff PR, Smith S, Milner M, French GL (2010) Two-step glutamate dehydrogenase antigen real-time polymerase chain reaction assay for detection of toxigenic Clostridium difficile. J Hosp Infect 74:48-54
13. Kato H, Kato N, Katow S, Maegawa T, Nakamura S, Lyerly DM (1999) Deletions in the repeating sequences of the toxin A gene of toxin A-negative, toxin B-positive Clostridium difficile strains. FEMS Microbiol Lett 175:197-203
14. Kato H, Kato N, Watanabe K, Iwai N, Nakamura H, Yamamoto Y, Suzuki K, Kim SM, Chong Y, Wasito EB (1998) Identification of toxin A-negative, toxin B-positive Clostridium difficile by PCR. J Clin Microbiol 36:2178-2182
15. Kawada M, Annaka M, Kato H, Shibasaki S, Hikosaka K, Mizuno H, Masuda Y, Inamatsu T (2011) Evaluation of a simultaneous detection kit for the glutamate dehydrogenase antigen and toxin A/B in feces for diagnosis of Clostridium difficile infection. J Infect Chemother 17:807-811
16. Knetsch CW, Bakker D, de Boer RF, Sanders I, Hofs S, Kooistra-Smid AM, Corver J, Eastwood K, Wilcox MH, Kuijper EJ (2011) Comparison of real-time PCR techniques to cytotoxigenic culture methods for diagnosing Clostridium difficile infection. J Clin Microbiol 49:227-231
17. Kufelnicka AM, Kirn TJ (2011) Effective utilization of evolving methods for the laboratory diagnosis of Clostridium difficile infection. Clin Infect Dis 52:1451-1457
18. Kuijper EJ, van Dissel JT, Wilcox MH (2007) Clostridium difficile: changing epidemiology and new treatment options. Curr Opin Infect Dis 20:376-383
19. Lalande V, Barrault L, Wadel S, Eckert C, Petit J, Barbut F (2011) Evaluation of a loop-mediated isothermal amplification assay for diagnosis of Clostridium difficile infections. J Clin Microbiol 49:2714-2716
20. Niesters HG (2002) Clinical virology in real time. J Clin Virol 25(Suppl 3):S3-S12
21. Notomi T, Okayama H, Masubuchi H, Yonekawa T, Watanabe K, Amino N, Hase T (2000) Loop-mediated isothermal amplification of DNA. Nucleic Acids Res 28:E63
22. Paltansing S, van den Berg RJ, Guseinova RA, Visser CE, van der Vorm ER, Kuijper EJ (2007) Characteristics and incidence of Clostridium difficile-associated disease in The Netherlands, 2005. Clin Microbiol Infect 13:1058-1064
23. Quinn CD, Sefers SE, Babiker W, He Y, Albacasa R, Stratton CW, Carroll KC, Tang Y (2010) C.Diff Quik Chek Complete enzyme immunoassay provides a reliable first-line method for detection of Clostridium difficile in stool specimens. J Clin Microbiol 48:603-605
24. Rupnik M, Wilcox MH, Gerding DN (2009) Clostridium difficile infection: new developments in epidemiology and pathogenesis. Nat Rev Microbiol 7:526-536
25. Sharp SE, Ruden LO, Pohl JC, Hatcher PA, Jayne LM, Ivie WM (2010) Evaluation of the C. Diff Quik Chek Complete assay, a new glutamate dehydrogenase and A/B toxin combination lateral flow assay for use in rapid, simple diagnosis of Clostridium difficile disease. J Clin Microbiol 48:2082-2086
26. Sloan LM, Duresko BJ, Gustafson DR, Rosenblatt JE (2008) Comparison of real-time PCR for detection of the tcdC gene with four toxin immunoassays and culture in diagnosis of Clostridium difficile infection. J Clin Microbiol 46:1996-2001
27. Swindells J, Brenwald N, Reading N, Oppenheim B (2010) Evaluation of diagnostic tests for Clostridium difficile infection. J Clin Microbiol 48:606-608
28. Tenover FC, Baron EJ, Peterson LR, Persing DH (2011) Laboratory diagnosis of Clostridium difficile infection can molecular amplification methods move us out of uncertainty? J Mol Diagn 13:573-582
29. Tenover FC, Novak-Weekley S, Woods CW, Peterson LR, Davis T, Schreckenberger P, Fang FC, Dascal A, Gerding DN, Nomura JH, Goering RV, Akerlund T, Weissfeld AS, Baron EJ, Wong E, Marlowe EM, Whitmore J, Persing DH (2010) Impact of strain type on detection of toxigenic Clostridium difficile: comparison of molecular diagnostic and enzyme immunoassay approaches. J Clin Microbiol 48:3719-3724
30. Ticehurst JR, Aird DZ, Dam LM, Borek AP, Hargrove JT, Carroll KC (2006) Effective detection of toxigenic Clostridium difficile by a two-step algorithm including tests for antigen and cytotoxin. J Clin Microbiol 44:1145-1149
31. Van den Berg RJ, Kuijper EJ, van Coppenraet LE, Claas EC (2006) Rapid diagnosis of toxinogenic Clostridium difficile in faecal samples with internally controlled real-time PCR. Clin Microbiol Infect 12:184-186